集団スクリーニングの世界市場

集団スクリーニングの世界市場は2030年までに353億米ドルに達する見込み

2024年に272億米ドルと推定される集団スクリーニングの世界市場は、2024～2030年の分析期間においてCAGR 4.5%で成長し、2030年には353億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである国家別スクリーニングは、CAGR 5.1％を記録し、分析期間終了までに257億米ドルに達すると予想されます。州別スクリーニング分野の成長率は、分析期間中CAGR 2.9%と推定されます。

米国市場は74億米ドルと推定、中国はCAGR 8.2％で成長予測

米国の集団スクリーニング市場は、2024年に74億米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに73億米ドルの市場規模に達すると予測され、分析期間2024-2030年のCAGRは8.2%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ1.8%と3.5%と予測されています。欧州では、ドイツがCAGR 2.6%で成長すると予測されています。

集団スクリーニング市場- 主要動向と促進要因のまとめ

集団スクリーニングとは何か、なぜ公衆衛生にとって重要なのか？

集団スクリーニングは、無症状の個人の病気や遺伝的状態、危険因子を早期に特定するために考案された、公衆衛生におけるプロアクティブなアプローチです。症状のある個人の状態を確認する診断テストとは異なり、集団スクリーニングは症状が出る前に健康上の懸念を発見することを目的としており、早期介入、治療結果の改善、ヘルスケアコストの削減を可能にします。一般的な例としては、がん検診（マンモグラム、大腸内視鏡検査、HPV検査）、代謝異常や遺伝子異常の新生児検診、心血管リスク検診、感染症検診（HIV、肝炎、結核検査）などがあります。

世界各国の政府やヘルスケア機関は、疾病負担や死亡率を減らすために検診プログラムを実施しています。集団検診プログラムは歴史的に、パップスメアによる子宮頸がんの減少、脂質プロファイリングによる心血管健康の改善、遺伝的キャリア検診による遺伝性疾患の予防に効果的でした。慢性疾患や加齢に関連した疾患の有病率の増加に伴い、ヘルスケアシステムは、より多くの疾患をカバーし、新しいテクノロジーを統合し、人口統計学的、遺伝的、ライフスタイル的要因に基づいてリスク評価を個別化するために、集団スクリーニングの取り組みを拡大しています。

テクノロジーはどのように集団スクリーニングの手法を変革しているのか？

医療技術、人工知能（AI）、ビッグデータ解析の進歩により、集団スクリーニングプログラムの精度、効率性、拡張性が大幅に向上しています。最も画期的な開発のひとつは、放射線学と病理学におけるAIを活用した画像診断と機械学習アルゴリズムの使用です。AIはマンモグラム、肺スキャン、網膜画像を従来の方法よりも高い精度で解析することができ、偽陽性を減らし、がん、糖尿病性網膜症、神経変性疾患の早期発見を可能にします。

もうひとつの大きな飛躍的進歩は、リキッドバイオプシーやマルチがん早期発見（MCED）検査の台頭です。これらは血液サンプルを用いて、早期がんを示す循環腫瘍DNA（ctDNA）やその他のバイオマーカーを検出します。これらの非侵襲的検査は、従来の組織生検に代わる、より安全で簡便な検査であり、大規模なスクリーニング・プログラムに理想的です。さらに、ゲノミクスと全ゲノム配列決定（WGS）の進歩により、遺伝性疾患、薬理ゲノム反応、アルツハイマー病や糖尿病のような複雑な疾患に対する素因のスクリーニングが可能になりました。

ウェアラブルヘルス技術とデジタルバイオマーカーの統合も、スクリーニングの実施方法を再構築しています。スマートウォッチ、持続グルコースモニター、ECG搭載ウェアラブルなどのデバイスは、継続的な健康モニタリング、リアルタイムのデータ収集、不整脈、高血圧、代謝異常の早期発見を可能にします。これらの技術革新は、1回限りのスクリーニング検査から継続的な健康監視への移行を可能にし、ヘルスケア提供者が異常な生理学的変化の兆候をいち早く察知して介入できるようにします。

集団スクリーニングの拡大を形作る主要動向とは？

集団スクリーニングの最も重要な動向の一つは、個別化されたリスクベースのスクリーニング・プロトコルへの移行です。従来、検診ガイドラインは年齢や幅広い集団の基準に基づいていましたが、精密医療やリスク層別化の新たな調査により、個人に合わせた検診の推奨が行われるようになってきています。例えば、40歳からの普遍的な乳がん検診の代わりに、遺伝的リスク評価と家族歴分析が、個人がより早く検診を開始すべきか、より頻繁に検診を受けるべきかを決定するのに役立っています。このアプローチにより、不必要な検査を最小限に抑えつつ、高リスク者の転帰を改善することができます。

在宅検診や自己検診の拡大もまた、ヘルスケアへのアクセスの変化を促しています。COVID-19の大流行により、在宅診断検査、遠隔医療相談、郵送検体採取キットの導入が加速し、その後HPV、大腸がん、感染症スクリーニングにも拡大した。このような分散型モデルは、特に農村部や医療施設へのアクセスが限られている人々にとって、より高い参加率、ヘルスケア格差の縮小、利便性の向上を可能にします。

もう一つの成長動向は、職場の健康増進プログラムや官民パートナーシップに集団スクリーニングを組み込むことです。大企業や保険会社は、病気の早期発見が長期的な医療費を削減し、労働者の生産性を向上させることを認識し、従業員の福利厚生の一環として予防検診を提供するようになっています。同様に、公衆衛生機関は民間バイオテクノロジー企業と協力し、大規模に展開できる費用対効果の高いAIを活用した検診ソリューションを開発しています。こうしたパートナーシップは、スクリーニング・イニシアチブへのアクセスを拡大し、公衆衛生の成果を最適化するのに役立っています。

集団スクリーニング市場の成長を促進する要因は？

集団スクリーニング市場の成長は、技術の進歩、政府資金の増加、疾病適用範囲の拡大、非感染性疾患（NCDs）の有病率の上昇など、いくつかの要因によってもたらされます。がん、心血管疾患、糖尿病などの慢性疾患の世界の負担増は、早期発見による積極的な疾患管理の必要性を高めており、政府やヘルスケア機関はスクリーニングの取り組みを優先し、予防医療に多くの予算を割り当てるよう促しています。

もう1つの主要な推進力は、遺伝子配列決定とバイオマーカー分析のコストが低下し、高度なスクリーニング技術がより手頃な価格で利用しやすくなっていることです。次世代シークエンシング（NGS）とAIを活用した診断は現在、日常的なスクリーニングプログラムに組み込まれ、遺伝的素因、がん変異、自己免疫マーカーの早期同定を可能にしています。このため、特に米国、欧州、日本などの新興ヘルスケア市場では、遺伝子スクリーニングや精密スクリーニング技術の採用率が高まっています。

規制上の取り組みや政策改革も、組織的スクリーニング・プログラムの拡大に拍車をかけています。世界各国の政府は、がん検診の保険適用、新生児検診の拡大、感染症検査の義務化を実施しており、早期発見サービスの恩恵を受ける人口の割合が確実に増加しています。さらに、クラウド・コンピューティングとAI主導のデータ分析の進歩により、電子カルテ（EHR）の統合が改善され、患者の検診歴、危険因子、フォローアップ介入をより適切に追跡できるようになっています。

さらに、消費者主導型ヘルスケアとデジタルヘルスプラットフォームの役割は、個人の検診プログラムへの参加方法を再構築しています。消費者直結型（DTC）健康検査会社の台頭は、医師の紹介を必要とせず、自宅でスクリーニングキットや遺伝リスク評価を購入することで、個人が自分の健康を管理する力を与えています。予防ヘルスケアや長寿に焦点を当てた診断に対する消費者の意識が高まるにつれて、便利でテクノロジーを駆使したスクリーニング・ソリューションに対する需要は、世界的に加速し続けると予想されます。

セグメント

地域タイプ（全国スクリーニング、州別スクリーニング）、製品タイプ（ハードウェア機器、検査／ラボサービス、分析／解釈）、スクリーニングタイプ（集団スクリーニング、プレミアムスクリーニング）、事業タイプ（病院、調査機関、診断ラボ）

調査対象企業の例

• Abbott Laboratories
• Aduro
• Agilent Technologies
• ARUP Laboratories
• CHC Wellbeing
• eHealthScreenings
• Empower Health Services
• F. Hoffmann-La Roche Ltd.
• Gene by Gene, Ltd.
• Health Advocate
• Health Designs
• Illumina, Inc.
• LGC Limited
• Novogene Corporation
• Onsite Health Diagnostics
• QIAGEN N.V.
• Quest Diagnostics Incorporated
• Siemens Healthineers AG
• Thermo Fisher Scientific Inc.
• US Wellness

AIインテグレーション

私たちは、検証された専門家のコンテンツとAIツールで市場情報と競合情報を変革しています。

Global Industry Analystsは、LLMや業界固有のSLMを照会する一般的な規範に従う代わりに、ビデオ記録、ブログ、検索エンジン調査、膨大な量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

• 市場概要
• 主要企業
• 市場動向と促進要因
• 世界市場の見通し

第3章 市場分析

• 米国
• カナダ
• 日本
• 中国
• 欧州
• フランス
• ドイツ
• イタリア
• 英国
• スペイン
• ロシア
• その他欧州
• アジア太平洋
• オーストラリア
• インド
• 韓国
• その他アジア太平洋地域
• ラテンアメリカ
• アルゼンチン
• ブラジル
• メキシコ
• その他ラテンアメリカ
• 中東
• イラン
• イスラエル
• サウジアラビア
• アラブ首長国連邦
• その他中東
• アフリカ

第4章 競合

Global Population Screening Market to Reach US$35.3 Billion by 2030

The global market for Population Screening estimated at US$27.2 Billion in the year 2024, is expected to reach US$35.3 Billion by 2030, growing at a CAGR of 4.5% over the analysis period 2024-2030. National Screening, one of the segments analyzed in the report, is expected to record a 5.1% CAGR and reach US$25.7 Billion by the end of the analysis period. Growth in the State-wise Screening segment is estimated at 2.9% CAGR over the analysis period.

The U.S. Market is Estimated at US$7.4 Billion While China is Forecast to Grow at 8.2% CAGR

The Population Screening market in the U.S. is estimated at US$7.4 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$7.3 Billion by the year 2030 trailing a CAGR of 8.2% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.8% and 3.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.6% CAGR.

Population Screening Market - Key Trends & Drivers Summarized

What Is Population Screening and Why Is It Crucial for Public Health?

Population screening is a proactive approach in public health designed to identify diseases, genetic conditions, or risk factors in asymptomatic individuals at an early stage. Unlike diagnostic tests, which confirm a condition in individuals with symptoms, population screening aims to detect health concerns before symptoms develop, allowing for early intervention, improved treatment outcomes, and reduced healthcare costs. Common examples include cancer screening (mammograms, colonoscopies, and HPV tests), newborn screening for metabolic and genetic disorders, cardiovascular risk screening, and infectious disease screening (HIV, hepatitis, and tuberculosis tests).

Governments and healthcare organizations worldwide implement screening programs to reduce disease burden and mortality rates. Mass screening programs have historically been effective in reducing cervical cancer through Pap smears, improving cardiovascular health through lipid profiling, and preventing hereditary conditions through genetic carrier screening. With the increasing prevalence of chronic diseases and age-related conditions, healthcare systems are expanding population screening efforts to cover more conditions, integrate new technologies, and personalize risk assessment based on demographic, genetic, and lifestyle factors.

How Is Technology Revolutionizing Population Screening Methods?

Advancements in medical technology, artificial intelligence (AI), and big data analytics are significantly improving the accuracy, efficiency, and scalability of population screening programs. One of the most transformative developments is the use of AI-powered imaging and machine learning algorithms in radiology and pathology. AI can analyze mammograms, lung scans, and retinal images with higher accuracy than traditional methods, reducing false positives and enabling earlier detection of cancer, diabetic retinopathy, and neurodegenerative diseases.

Another major breakthrough is the rise of liquid biopsy and multi-cancer early detection (MCED) tests, which use blood samples to detect circulating tumor DNA (ctDNA) and other biomarkers indicative of early-stage cancers. These non-invasive tests offer a safer and more convenient alternative to traditional tissue biopsies, making them ideal for large-scale screening programs. Additionally, advancements in genomics and whole-genome sequencing (WGS) have made it possible to screen individuals for inherited diseases, pharmacogenomic responses, and predisposition to complex conditions like Alzheimer's and diabetes.

The integration of wearable health technology and digital biomarkers is also reshaping how screening is conducted. Devices such as smartwatches, continuous glucose monitors, and ECG-equipped wearables allow for continuous health monitoring, real-time data collection, and early detection of arrhythmias, hypertension, and metabolic disorders. These innovations enable a shift from one-time screening tests to ongoing health surveillance, allowing healthcare providers to intervene at the earliest signs of abnormal physiological changes.

What Are the Key Trends Shaping the Expansion of Population Screening?

One of the most significant trends in population screening is the move toward personalized and risk-based screening protocols. Traditionally, screening guidelines were based on age and broad population criteria, but emerging research in precision medicine and risk stratification is leading to tailored screening recommendations. For example, instead of universal breast cancer screening starting at age 40, genetic risk assessment and family history analysis now help determine whether an individual should start earlier or undergo more frequent screenings. This approach minimizes unnecessary tests while improving outcomes for high-risk individuals.

The expansion of home-based and self-administered screening tests is also driving a shift in healthcare accessibility. The COVID-19 pandemic accelerated the adoption of at-home diagnostic tests, telemedicine consultations, and mail-in sample collection kits, which have since been expanded to HPV, colorectal cancer, and infectious disease screening. These decentralized models allow for higher participation rates, reduced healthcare disparities, and increased convenience, especially for populations in rural areas or those with limited access to medical facilities.

Another growing trend is the integration of population screening into workplace wellness programs and public-private partnerships. Large corporations and insurance providers are now offering preventive health screenings as part of employee benefits, recognizing that early disease detection reduces long-term medical costs and improves workforce productivity. Similarly, public health agencies are collaborating with private biotech firms to develop cost-effective, AI-powered screening solutions that can be deployed at scale. These partnerships help expand access to screening initiatives and optimize public health outcomes.

What Factors Are Driving the Growth of the Population Screening Market?

The growth in the population screening market is driven by several factors, including technological advancements, increased government funding, expanding disease coverage, and the rising prevalence of non-communicable diseases (NCDs). The increasing global burden of chronic diseases such as cancer, cardiovascular disease, and diabetes has heightened the need for proactive disease management through early detection, prompting governments and healthcare organizations to prioritize screening initiatives and allocate larger budgets for preventive care.

Another key driver is the falling costs of genetic sequencing and biomarker analysis, making advanced screening technologies more affordable and accessible. Next-generation sequencing (NGS) and AI-powered diagnostics are now being integrated into routine screening programs, allowing for early identification of genetic predispositions, cancer mutations, and autoimmune markers. This has led to higher adoption rates of genetic and precision screening techniques, particularly in developed healthcare markets such as the United States, Europe, and Japan.

Regulatory initiatives and policy reforms are also fueling the expansion of organized screening programs. Governments worldwide are implementing mandates for cancer screening coverage, newborn screening expansion, and infectious disease testing, ensuring that a larger percentage of the population benefits from early detection services. Additionally, advances in cloud computing and AI-driven data analytics are improving electronic health records (EHR) integration, allowing for better tracking of patient screening histories, risk factors, and follow-up interventions.

Furthermore, the role of consumer-driven healthcare and digital health platforms is reshaping how individuals participate in screening programs. The rise of direct-to-consumer (DTC) health testing companies has empowered individuals to take control of their health by purchasing at-home screening kits and genetic risk assessments without requiring physician referrals. As consumer awareness about preventive healthcare and longevity-focused diagnostics grows, the demand for convenient, technology-enabled screening solutions is expected to continue accelerating worldwide.

SCOPE OF STUDY:

The report analyzes the Population Screening market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Region Type (National Screening, State-wise Screening); Product Type (Hardware Equipment, Testing / Lab Services, Analytics / Interpretation); Screening Type (Mass Screening, Premium Screening); Business Type (Hospitals, Research Institutes, Diagnostic Labs)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 44 Featured) -

• Abbott Laboratories
• Aduro
• Agilent Technologies
• ARUP Laboratories
• CHC Wellbeing
• eHealthScreenings
• Empower Health Services
• F. Hoffmann-La Roche Ltd.
• Gene by Gene, Ltd.
• Health Advocate
• Health Designs
• Illumina, Inc.
• LGC Limited
• Novogene Corporation
• Onsite Health Diagnostics
• QIAGEN N.V.
• Quest Diagnostics Incorporated
• Siemens Healthineers AG
• Thermo Fisher Scientific Inc.
• US Wellness

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • Tariff Impact on Global Supply Chain Patterns
  • Population Screening - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Rising Healthcare Awareness Drives Adoption of Population Screening Programs
  • Increasing Incidence of Chronic Diseases Accelerates Demand for Screening Solutions
  • Growing Focus on Preventive Healthcare Strengthens the Business Case for Population Screening
  • Advances in Genetic Testing and Biotechnology Propel Growth of Genetic Screening Programs
  • Shift Towards Personalized Medicine Expands Addressable Market Opportunity for Population Screening
  • Regulatory Push for Early Detection of Diseases Sparks Demand for Screening Services
  • Technology Innovations in Screening Tools Enhance Diagnostic Accuracy and Drive Market Growth
  • Integration of Artificial Intelligence and Machine Learning in Screening Platforms Drives Adoption
  • Public Health Initiatives Promote Widespread Adoption of Population Screening Programs
  • Expansion of Healthcare Infrastructure in Emerging Markets Fuels Growth in Screening Demand
  • Growing Aging Population Drives the Need for Regular Screening and Early Disease Detection
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Population Screening Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Population Screening by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Population Screening by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 4: World 15-Year Perspective for Population Screening by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for National Screening by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for National Screening by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 7: World 15-Year Perspective for National Screening by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for State-wise Screening by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for State-wise Screening by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 10: World 15-Year Perspective for State-wise Screening by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Diagnostic Labs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Diagnostic Labs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 13: World 15-Year Perspective for Diagnostic Labs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 16: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 19: World 15-Year Perspective for Research Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Hardware Equipment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Hardware Equipment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 22: World 15-Year Perspective for Hardware Equipment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Testing / Lab Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Testing / Lab Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 25: World 15-Year Perspective for Testing / Lab Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Analytics / Interpretation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Analytics / Interpretation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 28: World 15-Year Perspective for Analytics / Interpretation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 29: World Recent Past, Current & Future Analysis for Mass Screening by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 30: World Historic Review for Mass Screening by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 31: World 15-Year Perspective for Mass Screening by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 32: World Recent Past, Current & Future Analysis for Premium Screening by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 33: World Historic Review for Premium Screening by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 34: World 15-Year Perspective for Premium Screening by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Population Screening Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 35: USA Recent Past, Current & Future Analysis for Population Screening by Region Type - National Screening and State-wise Screening - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 36: USA Historic Review for Population Screening by Region Type - National Screening and State-wise Screening Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 37: USA 15-Year Perspective for Population Screening by Region Type - Percentage Breakdown of Value Sales for National Screening and State-wise Screening for the Years 2015, 2025 & 2030
  • TABLE 38: USA Recent Past, Current & Future Analysis for Population Screening by Business Type - Diagnostic Labs, Hospitals and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 39: USA Historic Review for Population Screening by Business Type - Diagnostic Labs, Hospitals and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 40: USA 15-Year Perspective for Population Screening by Business Type - Percentage Breakdown of Value Sales for Diagnostic Labs, Hospitals and Research Institutes for the Years 2015, 2025 & 2030
  • TABLE 41: USA Recent Past, Current & Future Analysis for Population Screening by Product Type - Hardware Equipment, Testing / Lab Services and Analytics / Interpretation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 42: USA Historic Review for Population Screening by Product Type - Hardware Equipment, Testing / Lab Services and Analytics / Interpretation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 43: USA 15-Year Perspective for Population Screening by Product Type - Percentage Breakdown of Value Sales for Hardware Equipment, Testing / Lab Services and Analytics / Interpretation for the Years 2015, 2025 & 2030
  • TABLE 44: USA Recent Past, Current & Future Analysis for Population Screening by Screening Type - Mass Screening and Premium Screening - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 45: USA Historic Review for Population Screening by Screening Type - Mass Screening and Premium Screening Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 46: USA 15-Year Perspective for Population Screening by Screening Type - Percentage Breakdown of Value Sales for Mass Screening and Premium Screening for the Years 2015, 2025 & 2030
• CANADA
  • TABLE 47: Canada Recent Past, Current & Future Analysis for Population Screening by Region Type - National Screening and State-wise Screening - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 48: Canada Historic Review for Population Screening by Region Type - National Screening and State-wise Screening Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 49: Canada 15-Year Perspective for Population Screening by Region Type - Percentage Breakdown of Value Sales for National Screening and State-wise Screening for the Years 2015, 2025 & 2030
  • TABLE 50: Canada Recent Past, Current & Future Analysis for Population Screening by Business Type - Diagnostic Labs, Hospitals and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 51: Canada Historic Review for Population Screening by Business Type - Diagnostic Labs, Hospitals and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 52: Canada 15-Year Perspective for Population Screening by Business Type - Percentage Breakdown of Value Sales for Diagnostic Labs, Hospitals and Research Institutes for the Years 2015, 2025 & 2030
  • TABLE 53: Canada Recent Past, Current & Future Analysis for Population Screening by Product Type - Hardware Equipment, Testing / Lab Services and Analytics / Interpretation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 54: Canada Historic Review for Population Screening by Product Type - Hardware Equipment, Testing / Lab Services and Analytics / Interpretation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 55: Canada 15-Year Perspective for Population Screening by Product Type - Percentage Breakdown of Value Sales for Hardware Equipment, Testing / Lab Services and Analytics / Interpretation for the Years 2015, 2025 & 2030
  • TABLE 56: Canada Recent Past, Current & Future Analysis for Population Screening by Screening Type - Mass Screening and Premium Screening - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 57: Canada Historic Review for Population Screening by Screening Type - Mass Screening and Premium Screening Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 58: Canada 15-Year Perspective for Population Screening by Screening Type - Percentage Breakdown of Value Sales for Mass Screening and Premium Screening for the Years 2015, 2025 & 2030
• JAPAN
  • Population Screening Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 59: Japan Recent Past, Current & Future Analysis for Population Screening by Region Type - National Screening and State-wise Screening - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 60: Japan Historic Review for Population Screening by Region Type - National Screening and State-wise Screening Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 61: Japan 15-Year Perspective for Population Screening by Region Type - Percentage Breakdown of Value Sales for National Screening and State-wise Screening for the Years 2015, 2025 & 2030
  • TABLE 62: Japan Recent Past, Current & Future Analysis for Population Screening by Business Type - Diagnostic Labs, Hospitals and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 63: Japan Historic Review for Population Screening by Business Type - Diagnostic Labs, Hospitals and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 64: Japan 15-Year Perspective for Population Screening by Business Type - Percentage Breakdown of Value Sales for Diagnostic Labs, Hospitals and Research Institutes for the Years 2015, 2025 & 2030
  • TABLE 65: Japan Recent Past, Current & Future Analysis for Population Screening by Product Type - Hardware Equipment, Testing / Lab Services and Analytics / Interpretation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 66: Japan Historic Review for Population Screening by Product Type - Hardware Equipment, Testing / Lab Services and Analytics / Interpretation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 67: Japan 15-Year Perspective for Population Screening by Product Type - Percentage Breakdown of Value Sales for Hardware Equipment, Testing / Lab Services and Analytics / Interpretation for the Years 2015, 2025 & 2030
  • TABLE 68: Japan Recent Past, Current & Future Analysis for Population Screening by Screening Type - Mass Screening and Premium Screening - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 69: Japan Historic Review for Population Screening by Screening Type - Mass Screening and Premium Screening Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 70: Japan 15-Year Perspective for Population Screening by Screening Type - Percentage Breakdown of Value Sales for Mass Screening and Premium Screening for the Years 2015, 2025 & 2030
• CHINA
  • Population Screening Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 71: China Recent Past, Current & Future Analysis for Population Screening by Region Type - National Screening and State-wise Screening - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 72: China Historic Review for Population Screening by Region Type - National Screening and State-wise Screening Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 73: China 15-Year Perspective for Population Screening by Region Type - Percentage Breakdown of Value Sales for National Screening and State-wise Screening for the Years 2015, 2025 & 2030
  • TABLE 74: China Recent Past, Current & Future Analysis for Population Screening by Business Type - Diagnostic Labs, Hospitals and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 75: China Historic Review for Population Screening by Business Type - Diagnostic Labs, Hospitals and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 76: China 15-Year Perspective for Population Screening by Business Type - Percentage Breakdown of Value Sales for Diagnostic Labs, Hospitals and Research Institutes for the Years 2015, 2025 & 2030
  • TABLE 77: China Recent Past, Current & Future Analysis for Population Screening by Product Type - Hardware Equipment, Testing / Lab Services and Analytics / Interpretation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 78: China Historic Review for Population Screening by Product Type - Hardware Equipment, Testing / Lab Services and Analytics / Interpretation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 79: China 15-Year Perspective for Population Screening by Product Type - Percentage Breakdown of Value Sales for Hardware Equipment, Testing / Lab Services and Analytics / Interpretation for the Years 2015, 2025 & 2030
  • TABLE 80: China Recent Past, Current & Future Analysis for Population Screening by Screening Type - Mass Screening and Premium Screening - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 81: China Historic Review for Population Screening by Screening Type - Mass Screening and Premium Screening Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 82: China 15-Year Perspective for Population Screening by Screening Type - Percentage Breakdown of Value Sales for Mass Screening and Premium Screening for the Years 2015, 2025 & 2030
• EUROPE
  • Population Screening Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 83: Europe Recent Past, Current & Future Analysis for Population Screening by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 84: Europe Historic Review for Population Screening by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 85: Europe 15-Year Perspective for Population Screening by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
  • TABLE 86: Europe Recent Past, Current & Future Analysis for Population Screening by Region Type - National Screening and State-wise Screening - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 87: Europe Historic Review for Population Screening by Region Type - National Screening and State-wise Screening Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 88: Europe 15-Year Perspective for Population Screening by Region Type - Percentage Breakdown of Value Sales for National Screening and State-wise Screening for the Years 2015, 2025 & 2030
  • TABLE 89: Europe Recent Past, Current & Future Analysis for Population Screening by Business Type - Diagnostic Labs, Hospitals and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 90: Europe Historic Review for Population Screening by Business Type - Diagnostic Labs, Hospitals and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 91: Europe 15-Year Perspective for Population Screening by Business Type - Percentage Breakdown of Value Sales for Diagnostic Labs, Hospitals and Research Institutes for the Years 2015, 2025 & 2030
  • TABLE 92: Europe Recent Past, Current & Future Analysis for Population Screening by Product Type - Hardware Equipment, Testing / Lab Services and Analytics / Interpretation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 93: Europe Historic Review for Population Screening by Product Type - Hardware Equipment, Testing / Lab Services and Analytics / Interpretation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 94: Europe 15-Year Perspective for Population Screening by Product Type - Percentage Breakdown of Value Sales for Hardware Equipment, Testing / Lab Services and Analytics / Interpretation for the Years 2015, 2025 & 2030
  • TABLE 95: Europe Recent Past, Current & Future Analysis for Population Screening by Screening Type - Mass Screening and Premium Screening - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 96: Europe Historic Review for Population Screening by Screening Type - Mass Screening and Premium Screening Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 97: Europe 15-Year Perspective for Population Screening by Screening Type - Percentage Breakdown of Value Sales for Mass Screening and Premium Screening for the Years 2015, 2025 & 2030
• FRANCE
  • Population Screening Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 98: France Recent Past, Current & Future Analysis for Population Screening by Region Type - National Screening and State-wise Screening - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 99: France Historic Review for Population Screening by Region Type - National Screening and State-wise Screening Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 100: France 15-Year Perspective for Population Screening by Region Type - Percentage Breakdown of Value Sales for National Screening and State-wise Screening for the Years 2015, 2025 & 2030
  • TABLE 101: France Recent Past, Current & Future Analysis for Population Screening by Business Type - Diagnostic Labs, Hospitals and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 102: France Historic Review for Population Screening by Business Type - Diagnostic Labs, Hospitals and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 103: France 15-Year Perspective for Population Screening by Business Type - Percentage Breakdown of Value Sales for Diagnostic Labs, Hospitals and Research Institutes for the Years 2015, 2025 & 2030
  • TABLE 104: France Recent Past, Current & Future Analysis for Population Screening by Product Type - Hardware Equipment, Testing / Lab Services and Analytics / Interpretation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 105: France Historic Review for Population Screening by Product Type - Hardware Equipment, Testing / Lab Services and Analytics / Interpretation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 106: France 15-Year Perspective for Population Screening by Product Type - Percentage Breakdown of Value Sales for Hardware Equipment, Testing / Lab Services and Analytics / Interpretation for the Years 2015, 2025 & 2030
  • TABLE 107: France Recent Past, Current & Future Analysis for Population Screening by Screening Type - Mass Screening and Premium Screening - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 108: France Historic Review for Population Screening by Screening Type - Mass Screening and Premium Screening Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 109: France 15-Year Perspective for Population Screening by Screening Type - Percentage Breakdown of Value Sales for Mass Screening and Premium Screening for the Years 2015, 2025 & 2030
• GERMANY
  • Population Screening Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 110: Germany Recent Past, Current & Future Analysis for Population Screening by Region Type - National Screening and State-wise Screening - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 111: Germany Historic Review for Population Screening by Region Type - National Screening and State-wise Screening Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 112: Germany 15-Year Perspective for Population Screening by Region Type - Percentage Breakdown of Value Sales for National Screening and State-wise Screening for the Years 2015, 2025 & 2030
  • TABLE 113: Germany Recent Past, Current & Future Analysis for Population Screening by Business Type - Diagnostic Labs, Hospitals and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 114: Germany Historic Review for Population Screening by Business Type - Diagnostic Labs, Hospitals and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 115: Germany 15-Year Perspective for Population Screening by Business Type - Percentage Breakdown of Value Sales for Diagnostic Labs, Hospitals and Research Institutes for the Years 2015, 2025 & 2030
  • TABLE 116: Germany Recent Past, Current & Future Analysis for Population Screening by Product Type - Hardware Equipment, Testing / Lab Services and Analytics / Interpretation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 117: Germany Historic Review for Population Screening by Product Type - Hardware Equipment, Testing / Lab Services and Analytics / Interpretation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 118: Germany 15-Year Perspective for Population Screening by Product Type - Percentage Breakdown of Value Sales for Hardware Equipment, Testing / Lab Services and Analytics / Interpretation for the Years 2015, 2025 & 2030
  • TABLE 119: Germany Recent Past, Current & Future Analysis for Population Screening by Screening Type - Mass Screening and Premium Screening - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 120: Germany Historic Review for Population Screening by Screening Type - Mass Screening and Premium Screening Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 121: Germany 15-Year Perspective for Population Screening by Screening Type - Percentage Breakdown of Value Sales for Mass Screening and Premium Screening for the Years 2015, 2025 & 2030
• ITALY
  • TABLE 122: Italy Recent Past, Current & Future Analysis for Population Screening by Region Type - National Screening and State-wise Screening - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 123: Italy Historic Review for Population Screening by Region Type - National Screening and State-wise Screening Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 124: Italy 15-Year Perspective for Population Screening by Region Type - Percentage Breakdown of Value Sales for National Screening and State-wise Screening for the Years 2015, 2025 & 2030
  • TABLE 125: Italy Recent Past, Current & Future Analysis for Population Screening by Business Type - Diagnostic Labs, Hospitals and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 126: Italy Historic Review for Population Screening by Business Type - Diagnostic Labs, Hospitals and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 127: Italy 15-Year Perspective for Population Screening by Business Type - Percentage Breakdown of Value Sales for Diagnostic Labs, Hospitals and Research Institutes for the Years 2015, 2025 & 2030
  • TABLE 128: Italy Recent Past, Current & Future Analysis for Population Screening by Product Type - Hardware Equipment, Testing / Lab Services and Analytics / Interpretation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 129: Italy Historic Review for Population Screening by Product Type - Hardware Equipment, Testing / Lab Services and Analytics / Interpretation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 130: Italy 15-Year Perspective for Population Screening by Product Type - Percentage Breakdown of Value Sales for Hardware Equipment, Testing / Lab Services and Analytics / Interpretation for the Years 2015, 2025 & 2030
  • TABLE 131: Italy Recent Past, Current & Future Analysis for Population Screening by Screening Type - Mass Screening and Premium Screening - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 132: Italy Historic Review for Population Screening by Screening Type - Mass Screening and Premium Screening Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 133: Italy 15-Year Perspective for Population Screening by Screening Type - Percentage Breakdown of Value Sales for Mass Screening and Premium Screening for the Years 2015, 2025 & 2030
• UNITED KINGDOM
  • Population Screening Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 134: UK Recent Past, Current & Future Analysis for Population Screening by Region Type - National Screening and State-wise Screening - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 135: UK Historic Review for Population Screening by Region Type - National Screening and State-wise Screening Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 136: UK 15-Year Perspective for Population Screening by Region Type - Percentage Breakdown of Value Sales for National Screening and State-wise Screening for the Years 2015, 2025 & 2030
  • TABLE 137: UK Recent Past, Current & Future Analysis for Population Screening by Business Type - Diagnostic Labs, Hospitals and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 138: UK Historic Review for Population Screening by Business Type - Diagnostic Labs, Hospitals and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 139: UK 15-Year Perspective for Population Screening by Business Type - Percentage Breakdown of Value Sales for Diagnostic Labs, Hospitals and Research Institutes for the Years 2015, 2025 & 2030
  • TABLE 140: UK Recent Past, Current & Future Analysis for Population Screening by Product Type - Hardware Equipment, Testing / Lab Services and Analytics / Interpretation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 141: UK Historic Review for Population Screening by Product Type - Hardware Equipment, Testing / Lab Services and Analytics / Interpretation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 142: UK 15-Year Perspective for Population Screening by Product Type - Percentage Breakdown of Value Sales for Hardware Equipment, Testing / Lab Services and Analytics / Interpretation for the Years 2015, 2025 & 2030
  • TABLE 143: UK Recent Past, Current & Future Analysis for Population Screening by Screening Type - Mass Screening and Premium Screening - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 144: UK Historic Review for Population Screening by Screening Type - Mass Screening and Premium Screening Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 145: UK 15-Year Perspective for Population Screening by Screening Type - Percentage Breakdown of Value Sales for Mass Screening and Premium Screening for the Years 2015, 2025 & 2030
• SPAIN
  • TABLE 146: Spain Recent Past, Current & Future Analysis for Population Screening by Region Type - National Screening and State-wise Screening - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 147: Spain Historic Review for Population Screening by Region Type - National Screening and State-wise Screening Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 148: Spain 15-Year Perspective for Population Screening by Region Type - Percentage Breakdown of Value Sales for National Screening and State-wise Screening for the Years 2015, 2025 & 2030
  • TABLE 149: Spain Recent Past, Current & Future Analysis for Population Screening by Business Type - Diagnostic Labs, Hospitals and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 150: Spain Historic Review for Population Screening by Business Type - Diagnostic Labs, Hospitals and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 151: Spain 15-Year Perspective for Population Screening by Business Type - Percentage Breakdown of Value Sales for Diagnostic Labs, Hospitals and Research Institutes for the Years 2015, 2025 & 2030
  • TABLE 152: Spain Recent Past, Current & Future Analysis for Population Screening by Product Type - Hardware Equipment, Testing / Lab Services and Analytics / Interpretation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 153: Spain Historic Review for Population Screening by Product Type - Hardware Equipment, Testing / Lab Services and Analytics / Interpretation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 154: Spain 15-Year Perspective for Population Screening by Product Type - Percentage Breakdown of Value Sales for Hardware Equipment, Testing / Lab Services and Analytics / Interpretation for the Years 2015, 2025 & 2030
  • TABLE 155: Spain Recent Past, Current & Future Analysis for Population Screening by Screening Type - Mass Screening and Premium Screening - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 156: Spain Historic Review for Population Screening by Screening Type - Mass Screening and Premium Screening Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 157: Spain 15-Year Perspective for Population Screening by Screening Type - Percentage Breakdown of Value Sales for Mass Screening and Premium Screening for the Years 2015, 2025 & 2030
• RUSSIA
  • TABLE 158: Russia Recent Past, Current & Future Analysis for Population Screening by Region Type - National Screening and State-wise Screening - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 159: Russia Historic Review for Population Screening by Region Type - National Screening and State-wise Screening Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 160: Russia 15-Year Perspective for Population Screening by Region Type - Percentage Breakdown of Value Sales for National Screening and State-wise Screening for the Years 2015, 2025 & 2030
  • TABLE 161: Russia Recent Past, Current & Future Analysis for Population Screening by Business Type - Diagnostic Labs, Hospitals and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 162: Russia Historic Review for Population Screening by Business Type - Diagnostic Labs, Hospitals and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 163: Russia 15-Year Perspective for Population Screening by Business Type - Percentage Breakdown of Value Sales for Diagnostic Labs, Hospitals and Research Institutes for the Years 2015, 2025 & 2030
  • TABLE 164: Russia Recent Past, Current & Future Analysis for Population Screening by Product Type - Hardware Equipment, Testing / Lab Services and Analytics / Interpretation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 165: Russia Historic Review for Population Screening by Product Type - Hardware Equipment, Testing / Lab Services and Analytics / Interpretation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 166: Russia 15-Year Perspective for Population Screening by Product Type - Percentage Breakdown of Value Sales for Hardware Equipment, Testing / Lab Services and Analytics / Interpretation for the Years 2015, 2025 & 2030
  • TABLE 167: Russia Recent Past, Current & Future Analysis for Population Screening by Screening Type - Mass Screening and Premium Screening - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 168: Russia Historic Review for Population Screening by Screening Type - Mass Screening and Premium Screening Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 169: Russia 15-Year Perspective for Population Screening by Screening Type - Percentage Breakdown of Value Sales for Mass Screening and Premium Screening for the Years 2015, 2025 & 2030
• REST OF EUROPE
  • TABLE 170: Rest of Europe Recent Past, Current & Future Analysis for Population Screening by Region Type - National Screening and State-wise Screening - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 171: Rest of Europe Historic Review for Population Screening by Region Type - National Screening and State-wise Screening Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 172: Rest of Europe 15-Year Perspective for Population Screening by Region Type - Percentage Breakdown of Value Sales for National Screening and State-wise Screening for the Years 2015, 2025 & 2030
  • TABLE 173: Rest of Europe Recent Past, Current & Future Analysis for Population Screening by Business Type - Diagnostic Labs, Hospitals and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 174: Rest of Europe Historic Review for Population Screening by Business Type - Diagnostic Labs, Hospitals and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 175: Rest of Europe 15-Year Perspective for Population Screening by Business Type - Percentage Breakdown of Value Sales for Diagnostic Labs, Hospitals and Research Institutes for the Years 2015, 2025 & 2030
  • TABLE 176: Rest of Europe Recent Past, Current & Future Analysis for Population Screening by Product Type - Hardware Equipment, Testing / Lab Services and Analytics / Interpretation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 177: Rest of Europe Historic Review for Population Screening by Product Type - Hardware Equipment, Testing / Lab Services and Analytics / Interpretation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 178: Rest of Europe 15-Year Perspective for Population Screening by Product Type - Percentage Breakdown of Value Sales for Hardware Equipment, Testing / Lab Services and Analytics / Interpretation for the Years 2015, 2025 & 2030
  • TABLE 179: Rest of Europe Recent Past, Current & Future Analysis for Population Screening by Screening Type - Mass Screening and Premium Screening - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 180: Rest of Europe Historic Review for Population Screening by Screening Type - Mass Screening and Premium Screening Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 181: Rest of Europe 15-Year Perspective for Population Screening by Screening Type - Percentage Breakdown of Value Sales for Mass Screening and Premium Screening for the Years 2015, 2025 & 2030
• ASIA-PACIFIC
  • Population Screening Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 182: Asia-Pacific Recent Past, Current & Future Analysis for Population Screening by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 183: Asia-Pacific Historic Review for Population Screening by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 184: Asia-Pacific 15-Year Perspective for Population Screening by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
  • TABLE 185: Asia-Pacific Recent Past, Current & Future Analysis for Population Screening by Region Type - National Screening and State-wise Screening - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 186: Asia-Pacific Historic Review for Population Screening by Region Type - National Screening and State-wise Screening Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 187: Asia-Pacific 15-Year Perspective for Population Screening by Region Type - Percentage Breakdown of Value Sales for National Screening and State-wise Screening for the Years 2015, 2025 & 2030
  • TABLE 188: Asia-Pacific Recent Past, Current & Future Analysis for Population Screening by Business Type - Diagnostic Labs, Hospitals and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 189: Asia-Pacific Historic Review for Population Screening by Business Type - Diagnostic Labs, Hospitals and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 190: Asia-Pacific 15-Year Perspective for Population Screening by Business Type - Percentage Breakdown of Value Sales for Diagnostic Labs, Hospitals and Research Institutes for the Years 2015, 2025 & 2030
  • TABLE 191: Asia-Pacific Recent Past, Current & Future Analysis for Population Screening by Product Type - Hardware Equipment, Testing / Lab Services and Analytics / Interpretation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 192: Asia-Pacific Historic Review for Population Screening by Product Type - Hardware Equipment, Testing / Lab Services and Analytics / Interpretation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 193: Asia-Pacific 15-Year Perspective for Population Screening by Product Type - Percentage Breakdown of Value Sales for Hardware Equipment, Testing / Lab Services and Analytics / Interpretation for the Years 2015, 2025 & 2030
  • TABLE 194: Asia-Pacific Recent Past, Current & Future Analysis for Population Screening by Screening Type - Mass Screening and Premium Screening - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 195: Asia-Pacific Historic Review for Population Screening by Screening Type - Mass Screening and Premium Screening Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 196: Asia-Pacific 15-Year Perspective for Population Screening by Screening Type - Percentage Breakdown of Value Sales for Mass Screening and Premium Screening for the Years 2015, 2025 & 2030
• AUSTRALIA
  • Population Screening Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 197: Australia Recent Past, Current & Future Analysis for Population Screening by Region Type - National Screening and State-wise Screening - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 198: Australia Historic Review for Population Screening by Region Type - National Screening and State-wise Screening Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 199: Australia 15-Year Perspective for Population Screening by Region Type - Percentage Breakdown of Value Sales for National Screening and State-wise Screening for the Years 2015, 2025 & 2030
  • TABLE 200: Australia Recent Past, Current & Future Analysis for Population Screening by Business Type - Diagnostic Labs, Hospitals and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 201: Australia Historic Review for Population Screening by Business Type - Diagnostic Labs, Hospitals and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 202: Australia 15-Year Perspective for Population Screening by Business Type - Percentage Breakdown of Value Sales for Diagnostic Labs, Hospitals and Research Institutes for the Years 2015, 2025 & 2030
  • TABLE 203: Australia Recent Past, Current & Future Analysis for Population Screening by Product Type - Hardware Equipment, Testing / Lab Services and Analytics / Interpretation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 204: Australia Historic Review for Population Screening by Product Type - Hardware Equipment, Testing / Lab Services and Analytics / Interpretation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 205: Australia 15-Year Perspective for Population Screening by Product Type - Percentage Breakdown of Value Sales for Hardware Equipment, Testing / Lab Services and Analytics / Interpretation for the Years 2015, 2025 & 2030
  • TABLE 206: Australia Recent Past, Current & Future Analysis for Population Screening by Screening Type - Mass Screening and Premium Screening - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 207: Australia Historic Review for Population Screening by Screening Type - Mass Screening and Premium Screening Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 208: Australia 15-Year Perspective for Population Screening by Screening Type - Percentage Breakdown of Value Sales for Mass Screening and Premium Screening for the Years 2015, 2025 & 2030
• INDIA
  • Population Screening Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 209: India Recent Past, Current & Future Analysis for Population Screening by Region Type - National Screening and State-wise Screening - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 210: India Historic Review for Population Screening by Region Type - National Screening and State-wise Screening Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 211: India 15-Year Perspective for Population Screening by Region Type - Percentage Breakdown of Value Sales for National Screening and State-wise Screening for the Years 2015, 2025 & 2030
  • TABLE 212: India Recent Past, Current & Future Analysis for Population Screening by Business Type - Diagnostic Labs, Hospitals and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 213: India Historic Review for Population Screening by Business Type - Diagnostic Labs, Hospitals and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 214: India 15-Year Perspective for Population Screening by Business Type - Percentage Breakdown of Value Sales for Diagnostic Labs, Hospitals and Research Institutes for the Years 2015, 2025 & 2030
  • TABLE 215: India Recent Past, Current & Future Analysis for Population Screening by Product Type - Hardware Equipment, Testing / Lab Services and Analytics / Interpretation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 216: India Historic Review for Population Screening by Product Type - Hardware Equipment, Testing / Lab Services and Analytics / Interpretation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 217: India 15-Year Perspective for Population Screening by Product Type - Percentage Breakdown of Value Sales for Hardware Equipment, Testing / Lab Services and Analytics / Interpretation for the Years 2015, 2025 & 2030
  • TABLE 218: India Recent Past, Current & Future Analysis for Population Screening by Screening Type - Mass Screening and Premium Screening - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 219: India Historic Review for Population Screening by Screening Type - Mass Screening and Premium Screening Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 220: India 15-Year Perspective for Population Screening by Screening Type - Percentage Breakdown of Value Sales for Mass Screening and Premium Screening for the Years 2015, 2025 & 2030
• SOUTH KOREA
  • TABLE 221: South Korea Recent Past, Current & Future Analysis for Population Screening by Region Type - National Screening and State-wise Screening - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 222: South Korea Historic Review for Population Screening by Region Type - National Screening and State-wise Screening Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 223: South Korea 15-Year Perspective for Population Screening by Region Type - Percentage Breakdown of Value Sales for National Screening and State-wise Screening for the Years 2015, 2025 & 2030
  • TABLE 224: South Korea Recent Past, Current & Future Analysis for Population Screening by Business Type - Diagnostic Labs, Hospitals and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 225: South Korea Historic Review for Population Screening by Business Type - Diagnostic Labs, Hospitals and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 226: South Korea 15-Year Perspective for Population Screening by Business Type - Percentage Breakdown of Value Sales for Diagnostic Labs, Hospitals and Research Institutes for the Years 2015, 2025 & 2030
  • TABLE 227: South Korea Recent Past, Current & Future Analysis for Population Screening by Product Type - Hardware Equipment, Testing / Lab Services and Analytics / Interpretation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 228: South Korea Historic Review for Population Screening by Product Type - Hardware Equipment, Testing / Lab Services and Analytics / Interpretation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 229: South Korea 15-Year Perspective for Population Screening by Product Type - Percentage Breakdown of Value Sales for Hardware Equipment, Testing / Lab Services and Analytics / Interpretation for the Years 2015, 2025 & 2030
  • TABLE 230: South Korea Recent Past, Current & Future Analysis for Population Screening by Screening Type - Mass Screening and Premium Screening - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 231: South Korea Historic Review for Population Screening by Screening Type - Mass Screening and Premium Screening Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 232: South Korea 15-Year Perspective for Population Screening by Screening Type - Percentage Breakdown of Value Sales for Mass Screening and Premium Screening for the Years 2015, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 233: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Population Screening by Region Type - National Screening and State-wise Screening - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 234: Rest of Asia-Pacific Historic Review for Population Screening by Region Type - National Screening and State-wise Screening Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 235: Rest of Asia-Pacific 15-Year Perspective for Population Screening by Region Type - Percentage Breakdown of Value Sales for National Screening and State-wise Screening for the Years 2015, 2025 & 2030
  • TABLE 236: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Population Screening by Business Type - Diagnostic Labs, Hospitals and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 237: Rest of Asia-Pacific Historic Review for Population Screening by Business Type - Diagnostic Labs, Hospitals and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 238: Rest of Asia-Pacific 15-Year Perspective for Population Screening by Business Type - Percentage Breakdown of Value Sales for Diagnostic Labs, Hospitals and Research Institutes for the Years 2015, 2025 & 2030
  • TABLE 239: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Population Screening by Product Type - Hardware Equipment, Testing / Lab Services and Analytics / Interpretation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 240: Rest of Asia-Pacific Historic Review for Population Screening by Product Type - Hardware Equipment, Testing / Lab Services and Analytics / Interpretation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 241: Rest of Asia-Pacific 15-Year Perspective for Population Screening by Product Type - Percentage Breakdown of Value Sales for Hardware Equipment, Testing / Lab Services and Analytics / Interpretation for the Years 2015, 2025 & 2030
  • TABLE 242: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Population Screening by Screening Type - Mass Screening and Premium Screening - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 243: Rest of Asia-Pacific Historic Review for Population Screening by Screening Type - Mass Screening and Premium Screening Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 244: Rest of Asia-Pacific 15-Year Perspective for Population Screening by Screening Type - Percentage Breakdown of Value Sales for Mass Screening and Premium Screening for the Years 2015, 2025 & 2030
• LATIN AMERICA
  • Population Screening Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 245: Latin America Recent Past, Current & Future Analysis for Population Screening by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 246: Latin America Historic Review for Population Screening by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 247: Latin America 15-Year Perspective for Population Screening by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
  • TABLE 248: Latin America Recent Past, Current & Future Analysis for Population Screening by Region Type - National Screening and State-wise Screening - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 249: Latin America Historic Review for Population Screening by Region Type - National Screening and State-wise Screening Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 250: Latin America 15-Year Perspective for Population Screening by Region Type - Percentage Breakdown of Value Sales for National Screening and State-wise Screening for the Years 2015, 2025 & 2030
  • TABLE 251: Latin America Recent Past, Current & Future Analysis for Population Screening by Business Type - Diagnostic Labs, Hospitals and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 252: Latin America Historic Review for Population Screening by Business Type - Diagnostic Labs, Hospitals and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 253: Latin America 15-Year Perspective for Population Screening by Business Type - Percentage Breakdown of Value Sales for Diagnostic Labs, Hospitals and Research Institutes for the Years 2015, 2025 & 2030
  • TABLE 254: Latin America Recent Past, Current & Future Analysis for Population Screening by Product Type - Hardware Equipment, Testing / Lab Services and Analytics / Interpretation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 255: Latin America Historic Review for Population Screening by Product Type - Hardware Equipment, Testing / Lab Services and Analytics / Interpretation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 256: Latin America 15-Year Perspective for Population Screening by Product Type - Percentage Breakdown of Value Sales for Hardware Equipment, Testing / Lab Services and Analytics / Interpretation for the Years 2015, 2025 & 2030
  • TABLE 257: Latin America Recent Past, Current & Future Analysis for Population Screening by Screening Type - Mass Screening and Premium Screening - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 258: Latin America Historic Review for Population Screening by Screening Type - Mass Screening and Premium Screening Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 259: Latin America 15-Year Perspective for Population Screening by Screening Type - Percentage Breakdown of Value Sales for Mass Screening and Premium Screening for the Years 2015, 2025 & 2030
• ARGENTINA
  • TABLE 260: Argentina Recent Past, Current & Future Analysis for Population Screening by Region Type - National Screening and State-wise Screening - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 261: Argentina Historic Review for Population Screening by Region Type - National Screening and State-wise Screening Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 262: Argentina 15-Year Perspective for Population Screening by Region Type - Percentage Breakdown of Value Sales for National Screening and State-wise Screening for the Years 2015, 2025 & 2030
  • TABLE 263: Argentina Recent Past, Current & Future Analysis for Population Screening by Business Type - Diagnostic Labs, Hospitals and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 264: Argentina Historic Review for Population Screening by Business Type - Diagnostic Labs, Hospitals and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 265: Argentina 15-Year Perspective for Population Screening by Business Type - Percentage Breakdown of Value Sales for Diagnostic Labs, Hospitals and Research Institutes for the Years 2015, 2025 & 2030
  • TABLE 266: Argentina Recent Past, Current & Future Analysis for Population Screening by Product Type - Hardware Equipment, Testing / Lab Services and Analytics / Interpretation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 267: Argentina Historic Review for Population Screening by Product Type - Hardware Equipment, Testing / Lab Services and Analytics / Interpretation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 268: Argentina 15-Year Perspective for Population Screening by Product Type - Percentage Breakdown of Value Sales for Hardware Equipment, Testing / Lab Services and Analytics / Interpretation for the Years 2015, 2025 & 2030
  • TABLE 269: Argentina Recent Past, Current & Future Analysis for Population Screening by Screening Type - Mass Screening and Premium Screening - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 270: Argentina Historic Review for Population Screening by Screening Type - Mass Screening and Premium Screening Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 271: Argentina 15-Year Perspective for Population Screening by Screening Type - Percentage Breakdown of Value Sales for Mass Screening and Premium Screening for the Years 2015, 2025 & 2030
• BRAZIL
  • TABLE 272: Brazil Recent Past, Current & Future Analysis for Population Screening by Region Type - National Screening and State-wise Screening - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 273: Brazil Historic Review for Population Screening by Region Type - National Screening and State-wise Screening Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 274: Brazil 15-Year Perspective for Population Screening by Region Type - Percentage Breakdown of Value Sales for National Screening and State-wise Screening for the Years 2015, 2025 & 2030
  • TABLE 275: Brazil Recent Past, Current & Future Analysis for Population Screening by Business Type - Diagnostic Labs, Hospitals and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 276: Brazil Historic Review for Population Screening by Business Type - Diagnostic Labs, Hospitals and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 277: Brazil 15-Year Perspective for Population Screening by Business Type - Percentage Breakdown of Value Sales for Diagnostic Labs, Hospitals and Research Institutes for the Years 2015, 2025 & 2030
  • TABLE 278: Brazil Recent Past, Current & Future Analysis for Population Screening by Product Type - Hardware Equipment, Testing / Lab Services and Analytics / Interpretation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 279: Brazil Historic Review for Population Screening by Product Type - Hardware Equipment, Testing / Lab Services and Analytics / Interpretation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 280: Brazil 15-Year Perspective for Population Screening by Product Type - Percentage Breakdown of Value Sales for Hardware Equipment, Testing / Lab Services and Analytics / Interpretation for the Years 2015, 2025 & 2030
  • TABLE 281: Brazil Recent Past, Current & Future Analysis for Population Screening by Screening Type - Mass Screening and Premium Screening - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 282: Brazil Historic Review for Population Screening by Screening Type - Mass Screening and Premium Screening Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 283: Brazil 15-Year Perspective for Population Screening by Screening Type - Percentage Breakdown of Value Sales for Mass Screening and Premium Screening for the Years 2015, 2025 & 2030
• MEXICO
  • TABLE 284: Mexico Recent Past, Current & Future Analysis for Population Screening by Region Type - National Screening and State-wise Screening - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 285: Mexico Historic Review for Population Screening by Region Type - National Screening and State-wise Screening Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 286: Mexico 15-Year Perspective for Population Screening by Region Type - Percentage Breakdown of Value Sales for National Screening and State-wise Screening for the Years 2015, 2025 & 2030
  • TABLE 287: Mexico Recent Past, Current & Future Analysis for Population Screening by Business Type - Diagnostic Labs, Hospitals and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 288: Mexico Historic Review for Population Screening by Business Type - Diagnostic Labs, Hospitals and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 289: Mexico 15-Year Perspective for Population Screening by Business Type - Percentage Breakdown of Value Sales for Diagnostic Labs, Hospitals and Research Institutes for the Years 2015, 2025 & 2030
  • TABLE 290: Mexico Recent Past, Current & Future Analysis for Population Screening by Product Type - Hardware Equipment, Testing / Lab Services and Analytics / Interpretation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 291: Mexico Historic Review for Population Screening by Product Type - Hardware Equipment, Testing / Lab Services and Analytics / Interpretation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 292: Mexico 15-Year Perspective for Population Screening by Product Type - Percentage Breakdown of Value Sales for Hardware Equipment, Testing / Lab Services and Analytics / Interpretation for the Years 2015, 2025 & 2030
  • TABLE 293: Mexico Recent Past, Current & Future Analysis for Population Screening by Screening Type - Mass Screening and Premium Screening - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 294: Mexico Historic Review for Population Screening by Screening Type - Mass Screening and Premium Screening Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 295: Mexico 15-Year Perspective for Population Screening by Screening Type - Percentage Breakdown of Value Sales for Mass Screening and Premium Screening for the Years 2015, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 296: Rest of Latin America Recent Past, Current & Future Analysis for Population Screening by Region Type - National Screening and State-wise Screening - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 297: Rest of Latin America Historic Review for Population Screening by Region Type - National Screening and State-wise Screening Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 298: Rest of Latin America 15-Year Perspective for Population Screening by Region Type - Percentage Breakdown of Value Sales for National Screening and State-wise Screening for the Years 2015, 2025 & 2030
  • TABLE 299: Rest of Latin America Recent Past, Current & Future Analysis for Population Screening by Business Type - Diagnostic Labs, Hospitals and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 300: Rest of Latin America Historic Review for Population Screening by Business Type - Diagnostic Labs, Hospitals and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 301: Rest of Latin America 15-Year Perspective for Population Screening by Business Type - Percentage Breakdown of Value Sales for Diagnostic Labs, Hospitals and Research Institutes for the Years 2015, 2025 & 2030
  • TABLE 302: Rest of Latin America Recent Past, Current & Future Analysis for Population Screening by Product Type - Hardware Equipment, Testing / Lab Services and Analytics / Interpretation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 303: Rest of Latin America Historic Review for Population Screening by Product Type - Hardware Equipment, Testing / Lab Services and Analytics / Interpretation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 304: Rest of Latin America 15-Year Perspective for Population Screening by Product Type - Percentage Breakdown of Value Sales for Hardware Equipment, Testing / Lab Services and Analytics / Interpretation for the Years 2015, 2025 & 2030
  • TABLE 305: Rest of Latin America Recent Past, Current & Future Analysis for Population Screening by Screening Type - Mass Screening and Premium Screening - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 306: Rest of Latin America Historic Review for Population Screening by Screening Type - Mass Screening and Premium Screening Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 307: Rest of Latin America 15-Year Perspective for Population Screening by Screening Type - Percentage Breakdown of Value Sales for Mass Screening and Premium Screening for the Years 2015, 2025 & 2030
• MIDDLE EAST
  • Population Screening Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 308: Middle East Recent Past, Current & Future Analysis for Population Screening by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 309: Middle East Historic Review for Population Screening by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 310: Middle East 15-Year Perspective for Population Screening by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
  • TABLE 311: Middle East Recent Past, Current & Future Analysis for Population Screening by Region Type - National Screening and State-wise Screening - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 312: Middle East Historic Review for Population Screening by Region Type - National Screening and State-wise Screening Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 313: Middle East 15-Year Perspective for Population Screening by Region Type - Percentage Breakdown of Value Sales for National Screening and State-wise Screening for the Years 2015, 2025 & 2030
  • TABLE 314: Middle East Recent Past, Current & Future Analysis for Population Screening by Business Type - Diagnostic Labs, Hospitals and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 315: Middle East Historic Review for Population Screening by Business Type - Diagnostic Labs, Hospitals and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 316: Middle East 15-Year Perspective for Population Screening by Business Type - Percentage Breakdown of Value Sales for Diagnostic Labs, Hospitals and Research Institutes for the Years 2015, 2025 & 2030
  • TABLE 317: Middle East Recent Past, Current & Future Analysis for Population Screening by Product Type - Hardware Equipment, Testing / Lab Services and Analytics / Interpretation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 318: Middle East Historic Review for Population Screening by Product Type - Hardware Equipment, Testing / Lab Services and Analytics / Interpretation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 319: Middle East 15-Year Perspective for Population Screening by Product Type - Percentage Breakdown of Value Sales for Hardware Equipment, Testing / Lab Services and Analytics / Interpretation for the Years 2015, 2025 & 2030
  • TABLE 320: Middle East Recent Past, Current & Future Analysis for Population Screening by Screening Type - Mass Screening and Premium Screening - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 321: Middle East Historic Review for Population Screening by Screening Type - Mass Screening and Premium Screening Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 322: Middle East 15-Year Perspective for Population Screening by Screening Type - Percentage Breakdown of Value Sales for Mass Screening and Premium Screening for the Years 2015, 2025 & 2030
• IRAN
  • TABLE 323: Iran Recent Past, Current & Future Analysis for Population Screening by Region Type - National Screening and State-wise Screening - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 324: Iran Historic Review for Population Screening by Region Type - National Screening and State-wise Screening Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 325: Iran 15-Year Perspective for Population Screening by Region Type - Percentage Breakdown of Value Sales for National Screening and State-wise Screening for the Years 2015, 2025 & 2030
  • TABLE 326: Iran Recent Past, Current & Future Analysis for Population Screening by Business Type - Diagnostic Labs, Hospitals and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 327: Iran Historic Review for Population Screening by Business Type - Diagnostic Labs, Hospitals and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 328: Iran 15-Year Perspective for Population Screening by Business Type - Percentage Breakdown of Value Sales for Diagnostic Labs, Hospitals and Research Institutes for the Years 2015, 2025 & 2030
  • TABLE 329: Iran Recent Past, Current & Future Analysis for Population Screening by Product Type - Hardware Equipment, Testing / Lab Services and Analytics / Interpretation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 330: Iran Historic Review for Population Screening by Product Type - Hardware Equipment, Testing / Lab Services and Analytics / Interpretation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 331: Iran 15-Year Perspective for Population Screening by Product Type - Percentage Breakdown of Value Sales for Hardware Equipment, Testing / Lab Services and Analytics / Interpretation for the Years 2015, 2025 & 2030
  • TABLE 332: Iran Recent Past, Current & Future Analysis for Population Screening by Screening Type - Mass Screening and Premium Screening - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 333: Iran Historic Review for Population Screening by Screening Type - Mass Screening and Premium Screening Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 334: Iran 15-Year Perspective for Population Screening by Screening Type - Percentage Breakdown of Value Sales for Mass Screening and Premium Screening for the Years 2015, 2025 & 2030
• ISRAEL
  • TABLE 335: Israel Recent Past, Current & Future Analysis for Population Screening by Region Type - National Screening and State-wise Screening - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 336: Israel Historic Review for Population Screening by Region Type - National Screening and State-wise Screening Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 337: Israel 15-Year Perspective for Population Screening by Region Type - Percentage Breakdown of Value Sales for National Screening and State-wise Screening for the Years 2015, 2025 & 2030
  • TABLE 338: Israel Recent Past, Current & Future Analysis for Population Screening by Business Type - Diagnostic Labs, Hospitals and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 339: Israel Historic Review for Population Screening by Business Type - Diagnostic Labs, Hospitals and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 340: Israel 15-Year Perspective for Population Screening by Business Type - Percentage Breakdown of Value Sales for Diagnostic Labs, Hospitals and Research Institutes for the Years 2015, 2025 & 2030
  • TABLE 341: Israel Recent Past, Current & Future Analysis for Population Screening by Product Type - Hardware Equipment, Testing / Lab Services and Analytics / Interpretation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 342: Israel Historic Review for Population Screening by Product Type - Hardware Equipment, Testing / Lab Services and Analytics / Interpretation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 343: Israel 15-Year Perspective for Population Screening by Product Type - Percentage Breakdown of Value Sales for Hardware Equipment, Testing / Lab Services and Analytics / Interpretation for the Years 2015, 2025 & 2030
  • TABLE 344: Israel Recent Past, Current & Future Analysis for Population Screening by Screening Type - Mass Screening and Premium Screening - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 345: Israel Historic Review for Population Screening by Screening Type - Mass Screening and Premium Screening Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 346: Israel 15-Year Perspective for Population Screening by Screening Type - Percentage Breakdown of Value Sales for Mass Screening and Premium Screening for the Years 2015, 2025 & 2030
• SAUDI ARABIA
  • TABLE 347: Saudi Arabia Recent Past, Current & Future Analysis for Population Screening by Region Type - National Screening and State-wise Screening - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 348: Saudi Arabia Historic Review for Population Screening by Region Type - National Screening and State-wise Screening Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 349: Saudi Arabia 15-Year Perspective for Population Screening by Region Type - Percentage Breakdown of Value Sales for National Screening and State-wise Screening for the Years 2015, 2025 & 2030
  • TABLE 350: Saudi Arabia Recent Past, Current & Future Analysis for Population Screening by Business Type - Diagnostic Labs, Hospitals and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 351: Saudi Arabia Historic Review for Population Screening by Business Type - Diagnostic Labs, Hospitals and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 352: Saudi Arabia 15-Year Perspective for Population Screening by Business Type - Percentage Breakdown of Value Sales for Diagnostic Labs, Hospitals and Research Institutes for the Years 2015, 2025 & 2030
  • TABLE 353: Saudi Arabia Recent Past, Current & Future Analysis for Population Screening by Product Type - Hardware Equipment, Testing / Lab Services and Analytics / Interpretation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 354: Saudi Arabia Historic Review for Population Screening by Product Type - Hardware Equipment, Testing / Lab Services and Analytics / Interpretation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 355: Saudi Arabia 15-Year Perspective for Population Screening by Product Type - Percentage Breakdown of Value Sales for Hardware Equipment, Testing / Lab Services and Analytics / Interpretation for the Years 2015, 2025 & 2030
  • TABLE 356: Saudi Arabia Recent Past, Current & Future Analysis for Population Screening by Screening Type - Mass Screening and Premium Screening - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 357: Saudi Arabia Historic Review for Population Screening by Screening Type - Mass Screening and Premium Screening Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 358: Saudi Arabia 15-Year Perspective for Population Screening by Screening Type - Percentage Breakdown of Value Sales for Mass Screening and Premium Screening for the Years 2015, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 359: UAE Recent Past, Current & Future Analysis for Population Screening by Region Type - National Screening and State-wise Screening - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 360: UAE Historic Review for Population Screening by Region Type - National Screening and State-wise Screening Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 361: UAE 15-Year Perspective for Population Screening by Region Type - Percentage Breakdown of Value Sales for National Screening and State-wise Screening for the Years 2015, 2025 & 2030
  • TABLE 362: UAE Recent Past, Current & Future Analysis for Population Screening by Business Type - Diagnostic Labs, Hospitals and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 363: UAE Historic Review for Population Screening by Business Type - Diagnostic Labs, Hospitals and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 364: UAE 15-Year Perspective for Population Screening by Business Type - Percentage Breakdown of Value Sales for Diagnostic Labs, Hospitals and Research Institutes for the Years 2015, 2025 & 2030
  • TABLE 365: UAE Recent Past, Current & Future Analysis for Population Screening by Product Type - Hardware Equipment, Testing / Lab Services and Analytics / Interpretation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 366: UAE Historic Review for Population Screening by Product Type - Hardware Equipment, Testing / Lab Services and Analytics / Interpretation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 367: UAE 15-Year Perspective for Population Screening by Product Type - Percentage Breakdown of Value Sales for Hardware Equipment, Testing / Lab Services and Analytics / Interpretation for the Years 2015, 2025 & 2030
  • TABLE 368: UAE Recent Past, Current & Future Analysis for Population Screening by Screening Type - Mass Screening and Premium Screening - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 369: UAE Historic Review for Population Screening by Screening Type - Mass Screening and Premium Screening Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 370: UAE 15-Year Perspective for Population Screening by Screening Type - Percentage Breakdown of Value Sales for Mass Screening and Premium Screening for the Years 2015, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 371: Rest of Middle East Recent Past, Current & Future Analysis for Population Screening by Region Type - National Screening and State-wise Screening - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 372: Rest of Middle East Historic Review for Population Screening by Region Type - National Screening and State-wise Screening Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 373: Rest of Middle East 15-Year Perspective for Population Screening by Region Type - Percentage Breakdown of Value Sales for National Screening and State-wise Screening for the Years 2015, 2025 & 2030
  • TABLE 374: Rest of Middle East Recent Past, Current & Future Analysis for Population Screening by Business Type - Diagnostic Labs, Hospitals and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 375: Rest of Middle East Historic Review for Population Screening by Business Type - Diagnostic Labs, Hospitals and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 376: Rest of Middle East 15-Year Perspective for Population Screening by Business Type - Percentage Breakdown of Value Sales for Diagnostic Labs, Hospitals and Research Institutes for the Years 2015, 2025 & 2030
  • TABLE 377: Rest of Middle East Recent Past, Current & Future Analysis for Population Screening by Product Type - Hardware Equipment, Testing / Lab Services and Analytics / Interpretation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 378: Rest of Middle East Historic Review for Population Screening by Product Type - Hardware Equipment, Testing / Lab Services and Analytics / Interpretation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 379: Rest of Middle East 15-Year Perspective for Population Screening by Product Type - Percentage Breakdown of Value Sales for Hardware Equipment, Testing / Lab Services and Analytics / Interpretation for the Years 2015, 2025 & 2030
  • TABLE 380: Rest of Middle East Recent Past, Current & Future Analysis for Population Screening by Screening Type - Mass Screening and Premium Screening - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 381: Rest of Middle East Historic Review for Population Screening by Screening Type - Mass Screening and Premium Screening Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 382: Rest of Middle East 15-Year Perspective for Population Screening by Screening Type - Percentage Breakdown of Value Sales for Mass Screening and Premium Screening for the Years 2015, 2025 & 2030
• AFRICA
  • Population Screening Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 383: Africa Recent Past, Current & Future Analysis for Population Screening by Region Type - National Screening and State-wise Screening - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 384: Africa Historic Review for Population Screening by Region Type - National Screening and State-wise Screening Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 385: Africa 15-Year Perspective for Population Screening by Region Type - Percentage Breakdown of Value Sales for National Screening and State-wise Screening for the Years 2015, 2025 & 2030
  • TABLE 386: Africa Recent Past, Current & Future Analysis for Population Screening by Business Type - Diagnostic Labs, Hospitals and Research Institutes - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 387: Africa Historic Review for Population Screening by Business Type - Diagnostic Labs, Hospitals and Research Institutes Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 388: Africa 15-Year Perspective for Population Screening by Business Type - Percentage Breakdown of Value Sales for Diagnostic Labs, Hospitals and Research Institutes for the Years 2015, 2025 & 2030
  • TABLE 389: Africa Recent Past, Current & Future Analysis for Population Screening by Product Type - Hardware Equipment, Testing / Lab Services and Analytics / Interpretation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 390: Africa Historic Review for Population Screening by Product Type - Hardware Equipment, Testing / Lab Services and Analytics / Interpretation Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 391: Africa 15-Year Perspective for Population Screening by Product Type - Percentage Breakdown of Value Sales for Hardware Equipment, Testing / Lab Services and Analytics / Interpretation for the Years 2015, 2025 & 2030
  • TABLE 392: Africa Recent Past, Current & Future Analysis for Population Screening by Screening Type - Mass Screening and Premium Screening - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 393: Africa Historic Review for Population Screening by Screening Type - Mass Screening and Premium Screening Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 394: Africa 15-Year Perspective for Population Screening by Screening Type - Percentage Breakdown of Value Sales for Mass Screening and Premium Screening for the Years 2015, 2025 & 2030

IV. COMPETITION